Related Experiment Video
Updated: Jan 15, 2026

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
[Cannabis, CBD, THC : therapeutic potential, realities and latest discoveries]
Vicky Gilles1, Didier Wégimont2
1Service de Psychiatrie infanto-juvénile, CHU Liège, Belgique.
None:
This article aims to provide an update on the use of CBD in the fields of psychiatry, neurology and pediatrics. It details the pharmacological properties of cannabidiol (CBD), a non-psychoactive molecule of cannabis, and its interaction with various receptors in the nervous system. This article explores its potential therapeutic applications, especially for the treatment of epilepsy, chronic pain, anxiety disorders and neurodegenerative diseases. It also presents the CBD-based medications available in Belgium, the regulatory challenges and the scientific uncertainties surrounding their long-term efficacy and safety. Although CBD shows promise, further studies are needed to validate its clinical use and better understand its side effects and drug interactions.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Drug Discovery: Overview
Analgesia and Pain Management
Microorganisms in Medicine and Therapeutics

